US Stock MarketDetailed Quotes

EPIX ESSA Pharma

Watchlist
  • 5.250
  • +0.050+0.96%
Close Aug 28 16:00 ET
232.94MMarket Cap-8467P/E (TTM)

ESSA Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-2.20%8.88M
28.06%10.71M
-3.42%7.59M
-13.06%32.13M
-5.11%6.76M
-2.22%9.08M
-27.04%8.37M
-13.42%7.86M
-0.49%36.96M
-22.73%7.12M
Selling and administrative expenses
21.59%3.42M
16.75%4.54M
-6.11%2.42M
-7.44%11.37M
-24.63%2.09M
1.90%2.81M
4.39%3.89M
-14.80%2.58M
-3.88%12.28M
-5.04%2.77M
-General and administrative expense
21.59%3.42M
16.75%4.54M
-6.11%2.42M
-7.44%11.37M
-24.63%2.09M
1.90%2.81M
4.39%3.89M
-14.80%2.58M
-3.88%12.28M
-5.04%2.77M
Research and development costs
-12.87%5.46M
37.87%6.18M
0.61%5.38M
-12.67%21.32M
20.10%5.23M
-1.93%6.27M
-41.42%4.48M
-11.22%5.34M
0.64%24.42M
-30.63%4.35M
Depreciation amortization depletion
----
----
----
----
----
----
----
----
141.81%264.7K
-89.49%3.03K
-Depreciation and amortization
----
----
----
----
----
----
----
----
141.81%264.7K
-89.49%3.03K
Other operating expenses
----
----
-224.71%-207.1K
---554.4K
----
----
----
---63.78K
----
----
Operating profit
2.20%-8.88M
-28.06%-10.71M
3.42%-7.59M
13.06%-32.13M
5.11%-6.76M
2.22%-9.08M
27.04%-8.37M
13.42%-7.86M
0.49%-36.96M
22.73%-7.12M
Net non-operating interest income expense
0
0
0
221.95%5.55M
630.92%5.55M
-100.37%-1.53K
-100.41%-1.94K
-103.34%-2.35K
709.72%1.72M
904.46%759.68K
Non-operating interest income
----
----
----
219.80%5.55M
----
----
----
----
639.01%1.74M
856.58%762.43K
Non-operating interest expense
--0
--0
--0
-49.50%6.94K
-59.24%1.12K
-51.45%1.53K
-44.87%1.94K
-45.66%2.35K
-38.14%13.75K
-32.48%2.75K
Other net income (expense)
-7.63%1.65M
31.69%1.72M
45.07%1.63M
-70.38%6.53K
-14,827.55%-4.28M
62,816.94%1.79M
877.31%1.31M
1,404.53%1.12M
-75.78%22.04K
-104.94%-28.65K
Gain on sale of security
-7.63%1.65M
31.69%1.72M
45.07%1.63M
-70.38%6.53K
-14,827.55%-4.28M
62,816.94%1.79M
877.31%1.31M
1,404.53%1.12M
-75.78%22.04K
-104.94%-28.65K
Income before tax
0.89%-7.23M
-27.36%-8.99M
11.53%-5.96M
24.52%-26.58M
14.22%-5.48M
17.74%-7.3M
34.97%-7.06M
25.90%-6.74M
4.41%-35.22M
25.34%-6.39M
Income tax
0
0
101.43%1.6K
0
0
1.6K
-225.54%-111.82K
-66.15K
Net income
0.89%-7.23M
-27.33%-8.99M
11.53%-5.96M
24.27%-26.58M
13.32%-5.48M
17.31%-7.3M
34.96%-7.06M
25.90%-6.74M
4.62%-35.1M
26.12%-6.32M
Net income continuous Operations
0.89%-7.23M
-27.33%-8.99M
11.53%-5.96M
24.27%-26.58M
13.32%-5.48M
17.31%-7.3M
34.96%-7.06M
25.90%-6.74M
4.62%-35.1M
26.12%-6.32M
Minority interest income
Net income attributable to the parent company
0.89%-7.23M
-27.33%-8.99M
11.53%-5.96M
24.27%-26.58M
13.32%-5.48M
17.31%-7.3M
34.96%-7.06M
25.90%-6.74M
4.62%-35.1M
26.12%-6.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
0.89%-7.23M
-27.33%-8.99M
11.53%-5.96M
24.27%-26.58M
13.32%-5.48M
17.31%-7.3M
34.96%-7.06M
25.90%-6.74M
4.62%-35.1M
26.12%-6.32M
Basic earnings per share
5.88%-0.16
-25.00%-0.2
6.67%-0.14
25.00%-0.6
14.29%-0.12
15.00%-0.17
36.00%-0.16
28.57%-0.15
16.67%-0.8
30.00%-0.14
Diluted earnings per share
5.88%-0.16
-25.00%-0.2
6.67%-0.14
25.00%-0.6
14.29%-0.12
15.00%-0.17
36.00%-0.16
28.57%-0.15
16.67%-0.8
30.00%-0.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -2.20%8.88M28.06%10.71M-3.42%7.59M-13.06%32.13M-5.11%6.76M-2.22%9.08M-27.04%8.37M-13.42%7.86M-0.49%36.96M-22.73%7.12M
Selling and administrative expenses 21.59%3.42M16.75%4.54M-6.11%2.42M-7.44%11.37M-24.63%2.09M1.90%2.81M4.39%3.89M-14.80%2.58M-3.88%12.28M-5.04%2.77M
-General and administrative expense 21.59%3.42M16.75%4.54M-6.11%2.42M-7.44%11.37M-24.63%2.09M1.90%2.81M4.39%3.89M-14.80%2.58M-3.88%12.28M-5.04%2.77M
Research and development costs -12.87%5.46M37.87%6.18M0.61%5.38M-12.67%21.32M20.10%5.23M-1.93%6.27M-41.42%4.48M-11.22%5.34M0.64%24.42M-30.63%4.35M
Depreciation amortization depletion --------------------------------141.81%264.7K-89.49%3.03K
-Depreciation and amortization --------------------------------141.81%264.7K-89.49%3.03K
Other operating expenses ---------224.71%-207.1K---554.4K---------------63.78K--------
Operating profit 2.20%-8.88M-28.06%-10.71M3.42%-7.59M13.06%-32.13M5.11%-6.76M2.22%-9.08M27.04%-8.37M13.42%-7.86M0.49%-36.96M22.73%-7.12M
Net non-operating interest income expense 000221.95%5.55M630.92%5.55M-100.37%-1.53K-100.41%-1.94K-103.34%-2.35K709.72%1.72M904.46%759.68K
Non-operating interest income ------------219.80%5.55M----------------639.01%1.74M856.58%762.43K
Non-operating interest expense --0--0--0-49.50%6.94K-59.24%1.12K-51.45%1.53K-44.87%1.94K-45.66%2.35K-38.14%13.75K-32.48%2.75K
Other net income (expense) -7.63%1.65M31.69%1.72M45.07%1.63M-70.38%6.53K-14,827.55%-4.28M62,816.94%1.79M877.31%1.31M1,404.53%1.12M-75.78%22.04K-104.94%-28.65K
Gain on sale of security -7.63%1.65M31.69%1.72M45.07%1.63M-70.38%6.53K-14,827.55%-4.28M62,816.94%1.79M877.31%1.31M1,404.53%1.12M-75.78%22.04K-104.94%-28.65K
Income before tax 0.89%-7.23M-27.36%-8.99M11.53%-5.96M24.52%-26.58M14.22%-5.48M17.74%-7.3M34.97%-7.06M25.90%-6.74M4.41%-35.22M25.34%-6.39M
Income tax 00101.43%1.6K001.6K-225.54%-111.82K-66.15K
Net income 0.89%-7.23M-27.33%-8.99M11.53%-5.96M24.27%-26.58M13.32%-5.48M17.31%-7.3M34.96%-7.06M25.90%-6.74M4.62%-35.1M26.12%-6.32M
Net income continuous Operations 0.89%-7.23M-27.33%-8.99M11.53%-5.96M24.27%-26.58M13.32%-5.48M17.31%-7.3M34.96%-7.06M25.90%-6.74M4.62%-35.1M26.12%-6.32M
Minority interest income
Net income attributable to the parent company 0.89%-7.23M-27.33%-8.99M11.53%-5.96M24.27%-26.58M13.32%-5.48M17.31%-7.3M34.96%-7.06M25.90%-6.74M4.62%-35.1M26.12%-6.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 0.89%-7.23M-27.33%-8.99M11.53%-5.96M24.27%-26.58M13.32%-5.48M17.31%-7.3M34.96%-7.06M25.90%-6.74M4.62%-35.1M26.12%-6.32M
Basic earnings per share 5.88%-0.16-25.00%-0.26.67%-0.1425.00%-0.614.29%-0.1215.00%-0.1736.00%-0.1628.57%-0.1516.67%-0.830.00%-0.14
Diluted earnings per share 5.88%-0.16-25.00%-0.26.67%-0.1425.00%-0.614.29%-0.1215.00%-0.1736.00%-0.1628.57%-0.1516.67%-0.830.00%-0.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg